Actively Recruiting

Phase Not Applicable
Age: 15Years - 39Years
All Genders
ID07173205

Optimizing ASCENT: A Digital Intervention Trial for Depression in Adolescent and Young Adult Cancer Survivors

Led by East Carolina University · Updated on 2026-01-07

208

Participants Needed

2

Research Sites

12 weeks

Total Duration

On this page

Sponsors

E

East Carolina University

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a digital tool called the AYA Survivors Coping and Emotional Needs Toolkit (ASCENT) designed to help adolescent and young adult cancer survivors manage depression symptoms. This study aims to identify which parts or combinations of ASCENT's components contribute most to reducing depressive symptoms in young people who have completed cancer treatment. The study focuses on adolescents and young adults aged 15 to 39 who have finished cancer therapy within the past five years. Participants will be randomly assigned to one of sixteen conditions, each providing access to different combinations of ASCENT's components. All participants receive the core psychoeducation module about cancer survivorship and depression, plus daily mood tracking. Additional modules include positive psychology techniques, mindfulness training, cognitive restructuring, and behavioral activation. Each module contains micro-lessons with videos, stories, quizzes, open-ended questions, and practice activities, delivered digitally via smartphone. During the six-week intervention, participants complete mood tracking and engage with their assigned modules. Researchers measure changes in depressive symptoms from the start to week six, with a follow-up assessment at week twelve. Participants must have access to a smartphone and be fluent in English. Safety is monitored by excluding those with severe mental illness or suicidal intent. The study is sponsored by East Carolina University and aims to optimize depression support for young cancer survivors.

CONDITIONS

Brief Title

Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit

Who Can Participate

Age: 15Years - 39Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age at enrollment between 15 and 39 years
  • Age at cancer diagnosis between 12 and 39 years
  • Completed cancer treatment between 1 month and 5 years ago
  • Fluent in English (spoken and written)
  • Own a smartphone with a data plan
Not Eligible

You will not qualify if you...

  • Current diagnosis of severe or persistent mental illness
  • Severe suicidal ideation, including plan and intent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote)

Outpatient Treatment

Duration - 6 weeks

Participants receive access to the ASCENT digital depression self-management tool with psychoeducational content and various intervention modules depending on their assigned condition.

Weekly visits or check-ins for 6 weeks

Follow-up

Duration - 6 weeks

Participants are monitored for changes in depressive symptoms after the intervention period.

1 to 2 visits depending on assessment schedule

Trial Site Locations

Total: 2 locations

1

East Carolina University

Greenville, North Carolina, United States, 27858

Actively Recruiting

2

Wake Forest University

Winston-Salem, North Carolina, United States, 27109

Actively Recruiting

Loading map...

Research Team

A

AnneMarie Coffey, BS

L

Lane Williamson

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

FACTORIAL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

16

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here